Trial intelligence / Profile preview

Autologous Bone Marrow Stem Cells for Non-obstructive Azoospermia

NCT02041910Phase 2Unknown

Start
Jan 2014
Primary completion
Jan 2015
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 2, open-label trial in azoospermia (2 arms). Primary endpoint: Cases Improvement at 12 weeks. Status: unknown.

02

Conditions

azoospermia

Beyond the preview

Go deeper on NCT02041910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02041910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call